# A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins

> **NCT01350141** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 46 (actual)

## Conditions studied

- Hypercholesterolemia
- Dyslipidemia

## Interventions

- **OTHER:** Placebo
- **DRUG:** PF-04950615 (RN316)
- **DRUG:** PF-04950615 (RN316)

## Key facts

- **NCT ID:** NCT01350141
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-04
- **Final completion:** 2012-06
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01350141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01350141, "A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01350141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*